CDKN2B and laryngotracheoesophageal cleft: Moreover, qualification of miR-199a-5p in LC cells treated with si-CDKN2B-AS1 revealed notably higher miR-199a-5p expression in the si-CDKN2B-AS1 group than in the NC-CDKN2B-AS1 group (P < 0.05; Figure 6(e)) suggesting the targeted suppression of CDKN2B-AS1 on miR-199a-5p.